Teladoc Health Inc (TDOC)
12.79
+0.01
(+0.08%)
USD |
NYSE |
May 06, 16:00
12.75
-0.04
(-0.31%)
Pre-Market: 07:14
Teladoc Health Cash from Operations (Quarterly): 8.92M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.92M |
| December 31, 2023 | 130.08M |
| September 30, 2023 | 105.60M |
| June 30, 2023 | 101.18M |
| March 31, 2023 | 13.16M |
| December 31, 2022 | 65.55M |
| September 30, 2022 | 63.02M |
| June 30, 2022 | 92.47M |
| March 31, 2022 | -31.75M |
| December 31, 2021 | 83.21M |
| September 30, 2021 | 76.59M |
| June 30, 2021 | 52.22M |
| March 31, 2021 | -18.03M |
| December 31, 2020 | -114.94M |
| September 30, 2020 | 32.20M |
| June 30, 2020 | 35.55M |
| March 31, 2020 | -6.32M |
| December 31, 2019 | 18.12M |
| September 30, 2019 | 13.49M |
| June 30, 2019 | 6.149M |
| March 31, 2019 | -7.892M |
| Date | Value |
|---|---|
| December 31, 2018 | 2.476M |
| September 30, 2018 | 10.18M |
| June 30, 2018 | -3.646M |
| March 31, 2018 | -13.87M |
| December 31, 2017 | -7.275M |
| September 30, 2017 | -11.74M |
| June 30, 2017 | -2.914M |
| March 31, 2017 | -12.51M |
| December 31, 2016 | -7.534M |
| September 30, 2016 | -15.41M |
| June 30, 2016 | -11.75M |
| March 31, 2016 | -17.18M |
| December 31, 2015 | -12.80M |
| September 30, 2015 | -16.78M |
| June 30, 2015 | -7.259M |
| March 31, 2015 | -10.34M |
| December 31, 2014 | -4.284M |
| September 30, 2014 | -1.988M |
| June 30, 2014 | -2.891M |
| March 31, 2014 | -2.196M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-114.94M
Minimum
Dec 2020
130.08M
Maximum
Dec 2023
36.32M
Average
33.87M
Median
Cash from Operations (Quarterly) Benchmarks
| Omnicell Inc | 49.95M |
| Phreesia Inc | -3.078M |
| 10x Genomics Inc | -15.72M |
| Biote Corp | 6.956M |
| American Shared Hospital Services | -3.06M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -35.51M |
| Cash from Financing (Quarterly) | 1.751M |
| Free Cash Flow | 199.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1585 |
| Free Cash Flow to Equity (Quarterly) | -27.45M |
| Free Cash Flow to Firm (Quarterly) | -26.59M |
| Free Cash Flow Yield | 9.41% |